Bone Marrow TransplantationTissue DonorsTransplantation, HomologousHistocompatibility TestingBlood DonorsGraft vs Host DiseaseHistocompatibilityBone MarrowGraft SurvivalBone Marrow CellsTransplantation ChimeraWhole-Body IrradiationTransplantation, AutologousTransplantation ConditioningSurvival AnalysisAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationBone and BonesGraft RejectionTransplantation, IsogeneicLiver TransplantationRadiation ChimeraGraft Enhancement, ImmunologicTransplantation ToleranceHematopoietic Stem CellsKidney TransplantationLeukocyte TransfusionImmunosuppressive AgentsMice, Inbred C57BLBusulfanBone Marrow PurgingSkin TransplantationRecurrenceHLA AntigensImmunosuppressionTransplantation ImmunologyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionChimerismTreatment OutcomeHeart TransplantationActuarial AnalysisTime FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideBone Marrow DiseasesT-LymphocytesAcute DiseaseHematopoiesisCombined Modality TherapyLeukemia, Myeloid, AcuteBone Marrow ExaminationLymphocyte Culture Test, MixedHematologic NeoplasmsRemission InductionChimeraHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsGraft vs Host ReactionLiving DonorsMice, Inbred BALB CLeukemia, MyeloidStem Cell TransplantationLymphoma, Non-HodgkinLymphocyte TransfusionDisease-Free SurvivalRetrospective StudiesSevere Combined ImmunodeficiencyColony-Forming Units AssayMyelodysplastic SyndromesLung TransplantationCyclosporineBlood TransfusionHematologic DiseasesBone DensityMice, Inbred C3HImmune ToleranceCytomegalovirus InfectionsFlow CytometryOrgan TransplantationNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesCarmustineGraft vs Tumor EffectCell DifferentiationPancytopeniaLeukocyte CountSurvival RateGraft vs Leukemia EffectCytarabineSpleenGranulocyte Colony-Stimulating FactorBone ResorptionMelphalanCells, CulturedEtoposidePolymerase Chain Reaction